Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CSRA Insider Trading

CSRA | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at CSRA provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2017-08-25 00:01 2017-08-23 Batsakis George Officer - EVP, Chief Growth Officer SELL $31.42 28,392 $892,077 0 -100.0%
2017-08-23 01:23 2017-08-18 Reing John Officer - EVP, Chief HR Officer OPT+S $31,822.00 20,298 $645,922,956 2,628 0.0%
2017-08-17 23:55 2017-08-17 Martin Craig L Director BUY $32.31 20,000 $646,216 33,500 +148.1%
2017-06-05 15:31 2017-06-02 Prior Lawrence B III Director, Officer - President and CEO BUY $30.50 49,500 $1,509,943 76,270 +184.9%
2017-03-03 01:20 2017-03-01 Nedzbala Paul Officer - EVP, Health and Civil Group SELL $30.38 15,336 $465,908 405 -97.4%
2017-02-28 00:27 2017-02-23 Batsakis George Officer - EVP, Chief Growth Officer SELL $30.31 5,000 $151,564 28,392 -15.0%
2017-02-24 00:25 2017-02-21 Reing John Officer - EVP, Chief HR Officer SELL $30.55 13,107 $400,419 592 -95.7%
2016-12-14 01:30 2016-12-09 Batsakis George Officer - EVP, Chief Growth Officer SELL $32.60 6,000 $195,584 33,392 -15.2%
2016-11-24 00:04 2016-11-22 Reing John Officer - EVP, Chief HR Officer SELL $31.72 5,377 $170,558 592 -90.1%
2016-11-17 00:56 2016-11-14 Reing John Officer - EVP, Chief HR Officer SELL $31.30 15,000 $469,500 5,969 -71.5%
2016-09-16 00:36 2016-09-13 Prior Lawrence B III Director, Officer - President and CEO BUY $26.22 3,810 $99,898 26,142 +17.1%
2016-09-10 00:49 2016-09-07 Reing John Officer - EVP, Chief HR Officer OPT+S $26.63 12,926 $344,281 20,969 0.0%
2016-09-01 01:37 2016-08-30 Prior Lawrence B III Director, Officer - President and CEO BUY $25.54 3,918 $100,052 22,332 +21.3%
2016-08-17 01:40 2016-08-12 Nedzbala Paul Officer - EVP, Health and Civil Group OPT+S $26.00 15,467 $402,071 405 0.0%
2016-07-29 00:52 2016-07-26 LAWRIE JOHN M Director OPT+S $26.47 48,000 $1,270,555 402,113 0.0%
2016-06-03 04:52 2016-05-31 Nedzbala Paul Officer - EVP, Health and Civil Group OPT+S $24.50 24,401 $597,800 0 0.0%
2016-04-23 00:15 2016-04-20 LAWRIE JOHN M Director OPT+S $26.62 5,760 $153,348 378,173 0.0%
2016-04-23 00:14 2016-04-20 LAWRIE JOHN M Director SELL $26.58 4,640 $123,330 373,533 -1.2%
2016-04-07 00:34 2016-04-04 LAWRIE JOHN M Director SELL $27.00 18,900 $510,270 376,233 -4.8%
2016-04-07 00:33 2016-04-04 LAWRIE JOHN M Director SELL $26.77 2,700 $72,291 373,533 -0.7%
2016-03-02 04:24 2016-02-26 LAWRIE JOHN M Director SELL $27.39 100 $2,739 368,035 0.0%
2016-03-02 04:23 2016-02-26 LAWRIE JOHN M Director OPT+S $26.84 3,900 $104,689 368,135 0.0%
2016-03-02 04:04 2016-02-25 LAWRIE JOHN M Director OPT+S $26.45 5,399 $142,801 368,035 0.0%
2016-03-02 03:53 2016-01-26 LAWRIE JOHN M Director SELL $27.09 10,100 $273,560 368,035 -2.7%
2016-03-02 03:52 2016-01-26 LAWRIE JOHN M Director SELL $26.82 18,402 $493,521 378,135 -4.6%
2016-03-02 03:52 2016-01-26 LAWRIE JOHN M Director OPT+S $26.55 21,498 $570,727 396,537 0.0%
2016-03-01 02:58 2016-02-25 LAWRIE JOHN M Director OPT+S $26.45 5,399 $142,801 461,602 0.0%
2016-01-29 00:09 2016-01-26 LAWRIE JOHN M Director OPT+S $26.55 21,498 $570,727 28,502 0.0%
2016-01-29 00:08 2016-01-26 LAWRIE JOHN M Director SELL $27.09 10,100 $273,560 0 -100.0%
2016-01-29 00:08 2016-01-26 LAWRIE JOHN M Director SELL $26.82 18,402 $493,521 10,100 -64.6%
SHOW ENTRIES
1-30 OF 30

How to Interpret $CSRA Trades

Not every insider transaction in CSRA is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CSRA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CSRA

Insider activity data for CSRA is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CSRA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.